Charles Schwab’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,412
| Closed | -$34.6K | – | 3502 |
|
|
2024
Q4 | $34.6K | Buy |
3,412
+12
| +0.4% | +$122 | ﹤0.01% | 3461 |
|
|
2024
Q3 | $42.3K | Hold |
3,400
| – | – | ﹤0.01% | 3428 |
|
|
2024
Q2 | $44.2K | Sell |
3,400
-17,261
| -84% | -$225K | ﹤0.01% | 3522 |
|
|
2024
Q1 | $468K | Hold |
20,661
| – | – | ﹤0.01% | 3053 |
|
|
2023
Q4 | $268K | Buy |
20,661
+3,400
| +20% | +$44.1K | ﹤0.01% | 3236 |
|
|
2023
Q3 | $347K | Sell |
17,261
-3,029
| -15% | -$60.9K | ﹤0.01% | 3183 |
|
|
2023
Q2 | $545K | Buy |
20,290
+5,443
| +37% | +$146K | ﹤0.01% | 3006 |
|
|
2023
Q1 | $866K | Buy |
14,847
+1,058
| +8% | +$61.7K | ﹤0.01% | 2781 |
|
|
2022
Q4 | $703K | Buy |
13,789
+422
| +3% | +$21.5K | ﹤0.01% | 2899 |
|
|
2022
Q3 | $1.1M | Buy |
13,367
+35
| +0.3% | +$2.87K | ﹤0.01% | 2761 |
|
|
2022
Q2 | $902K | Buy |
13,332
+386
| +3% | +$26.1K | ﹤0.01% | 2833 |
|
|
2022
Q1 | $1.43M | Buy |
12,946
+403
| +3% | +$44.6K | ﹤0.01% | 2741 |
|
|
2021
Q4 | $1.21M | Hold |
12,543
| – | – | ﹤0.01% | 2839 |
|
|
2021
Q3 | $1.1M | Sell |
12,543
-18,461
| -60% | -$1.61M | ﹤0.01% | 2840 |
|
|
2021
Q2 | $4.8M | Buy |
31,004
+854
| +3% | +$132K | ﹤0.01% | 2374 |
|
|
2021
Q1 | $4.76M | Sell |
30,150
-988
| -3% | -$156K | ﹤0.01% | 2325 |
|
|
2020
Q4 | $7.23M | Sell |
31,138
-3,256
| -9% | -$756K | ﹤0.01% | 2042 |
|
|
2020
Q3 | $7.53M | Buy |
34,394
+4,813
| +16% | +$1.05M | ﹤0.01% | 1860 |
|
|
2020
Q2 | $8.41M | Buy |
29,581
+3,838
| +15% | +$1.09M | ﹤0.01% | 1746 |
|
|
2020
Q1 | $7.42M | Buy |
25,743
+2,385
| +10% | +$687K | ﹤0.01% | 1626 |
|
|
2019
Q4 | $6.72M | Buy |
23,358
+427
| +2% | +$123K | ﹤0.01% | 1869 |
|
|
2019
Q3 | $3.31M | Buy |
22,931
+2,647
| +13% | +$382K | ﹤0.01% | 2177 |
|
|
2019
Q2 | $1.82M | Buy |
20,284
+3,349
| +20% | +$301K | ﹤0.01% | 2400 |
|
|
2019
Q1 | $1.48M | Sell |
16,935
-988
| -6% | -$86.6K | ﹤0.01% | 2447 |
|
|
2018
Q4 | $2.52M | Sell |
17,923
-210
| -1% | -$29.5K | ﹤0.01% | 2239 |
|
|
2018
Q3 | $4.63M | Buy |
18,133
+972
| +6% | +$248K | ﹤0.01% | 2091 |
|
|
2018
Q2 | $4.37M | Buy |
17,161
+5,948
| +53% | +$1.52M | ﹤0.01% | 2068 |
|
|
2018
Q1 | $2.26M | Buy |
11,213
+1,194
| +12% | +$240K | ﹤0.01% | 2284 |
|
|
2017
Q4 | $1.44M | Buy |
10,019
+662
| +7% | +$95.3K | ﹤0.01% | 2414 |
|
|
2017
Q3 | $1.54M | Buy |
9,357
+1,621
| +21% | +$267K | ﹤0.01% | 2370 |
|
|
2017
Q2 | $1.05M | Buy |
7,736
+1,968
| +34% | +$267K | ﹤0.01% | 2435 |
|
|
2017
Q1 | $1.11M | Buy |
5,768
+251
| +5% | +$48.3K | ﹤0.01% | 2390 |
|
|
2016
Q4 | $778K | Buy |
5,517
+1,293
| +31% | +$182K | ﹤0.01% | 2500 |
|
|
2016
Q3 | $617K | Buy |
4,224
+191
| +5% | +$27.9K | ﹤0.01% | 2550 |
|
|
2016
Q2 | $406K | Buy |
4,033
+59
| +1% | +$5.94K | ﹤0.01% | 2666 |
|
|
2016
Q1 | $532K | Buy |
3,974
+71
| +2% | +$9.51K | ﹤0.01% | 2554 |
|
|
2015
Q4 | $776K | Buy |
3,903
+91
| +2% | +$18.1K | ﹤0.01% | 2474 |
|
|
2015
Q3 | $603K | Sell |
3,812
-246
| -6% | -$38.9K | ﹤0.01% | 2549 |
|
|
2015
Q2 | $1.66M | Buy |
4,058
+782
| +24% | +$319K | ﹤0.01% | 2184 |
|
|
2015
Q1 | $1.51M | Buy |
3,276
+1,211
| +59% | +$556K | ﹤0.01% | 2210 |
|
|
2014
Q4 | $1.16M | Buy |
2,065
+21
| +1% | +$11.8K | ﹤0.01% | 2286 |
|
|
2014
Q3 | $1.07M | Buy |
2,044
+446
| +28% | +$234K | ﹤0.01% | 2262 |
|
|
2014
Q2 | $1.12M | Buy |
1,598
+452
| +39% | +$316K | ﹤0.01% | 2266 |
|
|
2014
Q1 | $531K | Buy |
1,146
+28
| +3% | +$13K | ﹤0.01% | 2564 |
|
|
2013
Q4 | $385K | Buy |
+1,118
| New | +$385K | ﹤0.01% | 2686 |
|